Stock UniverseDerived research view · source repositories remain read-only

Jazz Pharmaceuticals plc (JAZZ)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
High
Selection Score
41.15
Global Rank
295
Market Cap
11.70B
Latest Close
238.57
RS Composite
23.85% · G#381

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
4.38%
3M
31.08%
6M
42.77%
1Y
117.97%
3Y
86.15%
5Y
33.93%
10Y
57.41%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 658.26K · 30-day average: 937.18K · Max drawdown over stored range: -52.10%

Research Snapshot

Relative Strength vs SPX

RS Composite23.85%
20D RS4.48%
60D RS19.69%
120D RS37.69%
Global RS Rank381 · 88.64% percentile
Qualified+ RS Rank152 · 87.92% percentile
Group ScopeQualified+
Primary RS Rank61 · 86.68% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank22 / 701
Primary Percentile97.00
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-054.44Bn/a-37.75M29.49M0.472.28B105.30M2.18B62Mn/a-0.85%0.66%51.43%49.05%1.84B4.32B

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$0.47505.5x$71.033.4x$34.846.8x$36.536.5x

Shares Diluted: 62M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue2363.5673094.2383659.3743834.2044068.954267.586
Revenue Growth (YoY)9.335%30.914%18.264%4.778%6.122%4.882%
Gross Profit2214.652876.5633392.2493550.0733758.2513912.238
Operating Income765.462475.263839.144810.726861.644989.07
Free Cash Flow884.644750.8661242.9311068.0451357.8381297.021
Free Cash Flow Per Share15.65312.57919.87414.8220.57121.269
EPS (Diluted) GAAP4.22-5.522632-3.5827246.1014628.648809-5.84031
EPS Growth-53.575%12900%12900%12900%41.75%
EPS Non-GAAP
Gross Margin93.699%92.965%92.7%92.59%92.364%91.673%
Operating Margin32.386%15.36%22.931%21.145%21.176%23.176%
Profit Margin10.096%-10.654%-6.123%10.819%13.766%-8.345%
Free Cash Flow Margin37.428%24.267%33.966%27.856%33.371%30.392%
Shares Outstanding (Diluted)56.51759.69462.53972.06666.00760.981
Shares Change (YoY)-1.795%5.621%4.766%15.234%-8.408%-7.614%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-051.07Bn/a336.60M31.49%293.10M27.42%4.4366.10M1.84B4.32Bprocessed
2025 Q42026-02-241.20Bn/a254.53M21.25%203.45M16.98%3.3361.06M1.39B4.33Bprocessed
2025 Q32025-11-051.13Bn/a57.51M5.11%251.41M22.33%4.0861.61M1.33B4.33Bprocessed
2025 Q22025-08-061.05Bn/a-686.39M-65.64%-718.47M-68.71%-11.7461.19M1.19B4.34Bprocessed
2025 Q12025-05-07897.84Mn/a-55.89M-6.23%-92.54M-10.31%-1.5260.98M1.86B5.34Bprocessed
2024 Q42025-02-261.09Bn/a190.77M17.53%191.12M17.56%3.1161.49M2.41B6.08Bprocessed
2024 Q32024-11-071.05Bn/a260.21M24.67%215.06M20.38%3.4263.17M2.22B6.08Bprocessed
2024 Q22024-08-011.02Bn/a199.44M19.48%168.57M16.46%2.4969.62M1.36B5.10Bprocessed
2024 Q12024-05-02901.98Mn/a66.21M7.34%-14.62M-1.62%-0.2362.54M1.44B5.11Bprocessed
2023 Q42024-02-281.01Bn/a122.50M12.11%94.15M9.30%1.3569.67M1.51B5.11Bprocessed
2023 Q32023-11-08972.14Mn/a172.39M17.73%146.82M15.10%2.1471.29M1.34B5.11Bprocessed
2023 Q22023-08-09957.32Mn/a157.64M16.47%104.44M10.91%1.5273.54M1.28B5.69Bprocessed
2023 Q12023-05-10892.81Mn/a126.06M14.12%69.42M7.78%1.0473.77M1.17B5.69Bprocessed
2022 Q42023-03-01972.12Mn/a-263.39M-27.09%-240.72M-24.76%-4.0159.99M881.48M5.69Bprocessed
2022 Q32022-11-09940.65Mn/a24.76M2.63%-19.65M-2.09%-0.3162.78M839.36M5.70Bprocessed
2022 Q22022-08-03932.88Mn/a85.55M9.17%34.66M3.72%0.5563.43M711.26M5.99Bprocessed
2022 Q12022-05-04813.72Mn/a87.55M10.76%1.65M0.20%0.0362.91M490.83M5.99Bprocessed
2021 Q42022-03-01896.73Mn/a49.38M5.51%-35.35M-3.94%-0.5761.52M591.45M6.02Bprocessed
2021 Q32021-11-09838.12Mn/a28.37M3.38%-52.83M-6.30%-0.8661.28M671.78M6.25Bprocessed
2021 Q22021-08-03751.81Mn/a-69.59M-9.26%-363.32M-48.33%-6.1159.45M891.40M6.49Bprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.